{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:33:28Z","timestamp":1793799208208,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12022-026-09917-z","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:17:46Z","timestamp":1778563066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Molecular Testing on Surgical Decision-Making in Indeterminate Thyroid Nodules: A Global Meta-Analysis Across Test Generations"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-5863","authenticated-orcid":false,"given":"Truong Phan-Xuan","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-5696","authenticated-orcid":false,"given":"Andrey","family":"Bychkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-3708","authenticated-orcid":false,"given":"Chan Kwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-7264","authenticated-orcid":false,"given":"Kennichi","family":"Kakudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-7689","authenticated-orcid":false,"given":"Chanchal","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"9917_CR1","doi-asserted-by":"publisher","unstructured":"Uppal N, Collins R, James B. Thyroid nodules: Global, economic, and personal burdens. Front Endocrinol [Internet]. 2023; Volume 14-2023. Available from: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/https:\/\/doi.org\/10.3389\/fendo.2023.1113977","DOI":"10.3389\/fendo.2023.1113977"},{"key":"9917_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/cncy.22228","volume":"128[4]","author":"HG Vuong","year":"2020","unstructured":"Vuong HG, Ngo HTT, Bychkov A, Jung CK, Vu TH, Lu KB, et al. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis. Cancer Cytopathol. 2020;128[4]:238\u201349. doi:https:\/\/doi.org\/10.1002\/cncy.22228","journal-title":"Cancer Cytopathol"},{"key":"9917_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26[1]","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26[1]:1\u2013133. doi:https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid."},{"key":"9917_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/thy.2023.0141","volume":"33[9]","author":"SZ Ali","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid Off J Am Thyroid Assoc. 2023;33[9]:1039\u201344. doi:https:\/\/doi.org\/10.1089\/thy.2023.0141 PubMed PMID: 37427847.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"9917_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1309\/AJCPPHLWMI3JV4LA","volume":"132[5]","author":"ES Cibas","year":"2009","unstructured":"Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132[5]:658\u201365. doi:https:\/\/doi.org\/10.1309\/AJCPPHLWMI3JV4LA","journal-title":"Am J Clin Pathol"},{"key":"9917_CR6","doi-asserted-by":"publisher","unstructured":"Chowdhury R, Hier J, Payne KE, Abdulhaleem M, Dimitstein O, Eisenbach N, et al. Impact of Molecular Testing on Surgical Decision-Making in Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis of Recent Advancements. Cancers. 2025;17[7]:1156. doi:https:\/\/doi.org\/10.3390\/cancers17071156","DOI":"10.3390\/cancers17071156"},{"key":"9917_CR7","doi-asserted-by":"publisher","unstructured":"Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? Cancer. 2017;123[3]:372\u201381. doi:https:\/\/doi.org\/10.1002\/cncr.30360","DOI":"10.1002\/cncr.30360"},{"key":"9917_CR8","doi-asserted-by":"publisher","unstructured":"Robenshtok E, Bachar G, Ritter A. Approach to the Patient with Thyroid Cancer: Selection and Management of Candidates for Lobectomy. J Clin Endocrinol Metab. 2025;110[7]: e2327\u201337. doi:https:\/\/doi.org\/10.1210\/clinem\/dgae903","DOI":"10.1210\/clinem\/dgae903"},{"key":"9917_CR9","doi-asserted-by":"crossref","unstructured":"Alzumaili B, Sadow PM. Update on Molecular Diagnostics in Thyroid Pathology: A Review. Genes. 2023;14[7]:1314. doi:10.3390\/genes14071314 PubMed PMID: 37510219; PubMed Central PMCID: PMC10379610.","DOI":"10.3390\/genes14071314"},{"key":"9917_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.32074\/1591-951","volume":"115[4]","author":"C Fumagalli","year":"2023","unstructured":"Fumagalli C, Serio G. Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making. Pathologica. 2023;115[4]:205\u201316. doi:https:\/\/doi.org\/10.32074\/1591-951X-887 PubMed PMID: 37711036; PubMed Central PMCID: PMC10688247.","journal-title":"Pathologica"},{"key":"9917_CR11","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/hed.27472","volume":"45[9]","author":"I Lon\u010dar","year":"2023","unstructured":"Lon\u010dar I, Van Velsen EFS, Massolt ET, Van Kemenade FJ, Van Engen-van Grunsven ACH, Van Hemel BM, et al. European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands. Head Neck. 2023;45[9]:2227\u201336. doi:https:\/\/doi.org\/10.1002\/hed.27472","journal-title":"Head Neck"},{"key":"9917_CR12","doi-asserted-by":"publisher","first-page":"17194","DOI":"10.18632\/oncotarget.7839","volume":"7[13]","author":"E Brauner","year":"2016","unstructured":"Brauner E, Gunda V, Vanden Borre P, Zurakowski D, Kim YS, Dennett KV, et al. Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer. Oncotarget. 2016;7[13]:17194\u2013211. doi:https:\/\/doi.org\/10.18632\/oncotarget.7839 PubMed PMID: 26943572; PubMed Central PMCID: PMC4941380.","journal-title":"Oncotarget"},{"key":"9917_CR13","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1210\/jc.2013-3584","volume":"99[11]","author":"B McIver","year":"2014","unstructured":"McIver B, Castro MR, Morris JC, Bernet V, Smallridge R, Henry M, et al. An Independent Study of a Gene Expression Classifier [Afirma] in the Evaluation of Cytologically Indeterminate Thyroid Nodules. J Clin Endocrinol Metab. 2014;99[11]:4069\u201377. doi:https:\/\/doi.org\/10.1210\/jc.2013-3584","journal-title":"J Clin Endocrinol Metab"},{"key":"9917_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/cncy.21749","volume":"124[10]","author":"WL Sacks","year":"2016","unstructured":"Sacks WL, Bose S, Zumsteg ZS, Wong R, Shiao SL, Braunstein GD, et al. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy. Cancer Cytopathol. 2016;124[10]:722\u20138. doi:https:\/\/doi.org\/10.1002\/cncy.21749","journal-title":"Cancer Cytopathol"},{"key":"9917_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1210\/jc.2013-2482","volume":"99[1]","author":"EK Alexander","year":"2014","unstructured":"Alexander EK, Schorr M, Klopper J, Kim C, Sipos J, Nabhan F, et al. Multicenter Clinical Experience with the Afirma Gene Expression Classifier. J Clin Endocrinol Metab. 2014;99[1]:119\u201325. doi:https:\/\/doi.org\/10.1210\/jc.2013-2482","journal-title":"J Clin Endocrinol Metab"},{"key":"9917_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jasc.2020.09.005","volume":"10[2]","author":"DA Abdelhakam","year":"2021","unstructured":"Abdelhakam DA, Mojica RE, Huenerberg KA, Nassar A. Impact of a genomic classifier on indeterminate thyroid nodules: an institutional experience. J Am Soc Cytopathol. 2021;10[2]:155\u201363. doi: https:\/\/doi.org\/10.1016\/j.jasc.2020.09.005","journal-title":"J Am Soc Cytopathol"},{"key":"9917_CR17","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1177\/00031348221109489","volume":"88[11]","author":"AB Barnes","year":"2022","unstructured":"Barnes AB, Justice-Clark T, Li W, Randle RW. Molecular Testing for Indeterminate Thyroid Nodules: Association of Negative Predictive Value with Nodule Size. Am Surg. 2022;88[11]:2745\u201351. doi:https:\/\/doi.org\/10.1177\/00031348221109489","journal-title":"Am Surg"},{"key":"9917_CR18","doi-asserted-by":"publisher","unstructured":"Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, Sipos JA, et al. Performance of a Multigene Genomic Classifier in Thyroid Nodules with Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019;5[2]:204. doi:https:\/\/doi.org\/10.1001\/jamaoncol.2018.4616","DOI":"10.1001\/jamaoncol.2018.4616"},{"key":"9917_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/cncy.22796","volume":"132[5]","author":"SP Yang","year":"2024","unstructured":"Yang SP, Nga ME, Bundele MM, Chiosea SI, Tan SH, Lum JHY, et al. Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules. Cancer Cytopathol. 2024;132[5]:309\u201319. doi:https:\/\/doi.org\/10.1002\/cncy.22796","journal-title":"Cancer Cytopathol"},{"key":"9917_CR20","unstructured":"Asian and Western practice in thyroid pathology: similarities and differences - Kakudo - Gland Surgery [Internet]. [cited 2025 Jul 30]. Available from: https:\/\/gs.amegroups.org\/article\/view\/43516\/39689"},{"key":"9917_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/cncy.22728","volume":"131[12]","author":"K Kakudo","year":"2023","unstructured":"Kakudo K, Liu Z, Jung CK, Lai C. Lessons learned from the diversity of thyroid nodule practice. Cancer Cytopathol. 2023;131[12]:741\u20136. doi:https:\/\/doi.org\/10.1002\/cncy.22728","journal-title":"Cancer Cytopathol"},{"key":"9917_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/cyt.12491","volume":"28[6]","author":"K Kakudo","year":"2017","unstructured":"Kakudo K, Higuchi M, Hirokawa M, Satoh S, Jung CK, Bychkov A. Thyroid FNA cytology in Asian Practice-Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas. Cytopathology. 2017;28[6]:455\u201366. doi:https:\/\/doi.org\/10.1111\/cyt.12491","journal-title":"Cytopathology"},{"key":"9917_CR23","doi-asserted-by":"publisher","unstructured":"Rana C, Vuong HG. Differences Among Thyroid FNA Practices Elucidated by Meta-analyses of the Literature. In: Kakudo K, Liu Z, Jung CK, Hirokawa M, Bychkov A, Lai CR, editors. Thyroid FNA Cytology [Internet]. Singapore: Springer Nature Singapore; 2023 [cited 2025 Feb 5]. p. 15\u201320. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-981-99-6782-7_3 doi:10.1007\/978-981-99-6782-7_3","DOI":"10.1007\/978-981-99-6782-7_3"},{"key":"9917_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/dc.24937","volume":"50[5]","author":"M Hirokawa","year":"2022","unstructured":"Hirokawa M, Suzuki A, Kawakami M, Kudo T, Miyauchi A. Criteria for follow-up of thyroid nodules diagnosed as follicular neoplasm without molecular testing - The experience of a high-volume thyroid centre in Japan. Diagn Cytopathol. 2022;50[5]:223\u20139. doi:https:\/\/doi.org\/10.1002\/dc.24937 PubMed PMID: 35133716; PubMed Central PMCID: PMC9304300.","journal-title":"Diagn Cytopathol"},{"key":"9917_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12022-020-09643-0","volume":"32[2]","author":"HTT Ngo","year":"2021","unstructured":"Ngo HTT, Nguyen TPX, Vu TH, Jung CK, Hassell L, Kakudo K, et al. Impact of Molecular Testing on the Management of Indeterminate Thyroid Nodules Among Western and Asian Countries: A Systematic Review and Meta-analysis. Endocr Pathol. 2021;32[2]:269\u201379. doi:https:\/\/doi.org\/10.1007\/s12022-020-09643-0","journal-title":"Endocr Pathol"},{"key":"9917_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4132\/jptm.2017.09.29","volume":"51[6]","author":"S Satoh","year":"2017","unstructured":"Satoh S, Yamashita H, Kakudo K. Thyroid Cytology: The Japanese System and Experience at Yamashita Thyroid Hospital. J Pathol Transl Med. 2017;51[6]:548\u201354. doi:https:\/\/doi.org\/10.4132\/jptm.2017.09.29","journal-title":"J Pathol Transl Med"},{"key":"9917_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74[3]","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying Publication Bias in Meta-Analysis. Biometrics. 2018;74[3]:785\u201394. doi:https:\/\/doi.org\/10.1111\/biom.12817","journal-title":"Biometrics"},{"key":"9917_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12672-016-0263-4","volume":"7[4]","author":"JP Abeykoon","year":"2016","unstructured":"Abeykoon JP, Mueller L, Dong F, Chintakuntlawar AV, Paludo J, Mortada R. The Effect of Implementing Gene Expression Classifier on Outcomes of Thyroid Nodules with Indeterminate Cytology. Horm Cancer. 2016;7[4]:272\u20138. doi:https:\/\/doi.org\/10.1007\/s12672-016-0263-4","journal-title":"Horm Cancer"},{"key":"9917_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0194599816652378","volume":"155[4]","author":"JK Dhingra","year":"2016","unstructured":"Dhingra JK. Office-Based Ultrasound\u2010Guided FNA with Molecular Testing for Thyroid Nodules. Otolaryngol Neck Surg. 2016;155[4]:564\u20137. doi:https:\/\/doi.org\/10.1177\/0194599816652378","journal-title":"Otolaryngol Neck Surg"},{"key":"9917_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/00034894241264380","volume":"133[10]","author":"S Garrett","year":"2024","unstructured":"Garrett S, Millay D, Pierre J, Pluta N, Russo C, Neelon D, et al. Monitoring Outcomes of Indeterminate Thyroid Nodules and Predictive Capabilities of Molecular Testing. Ann Otol Rhinol Laryngol. 2024;133[10]:873\u20138. doi:https:\/\/doi.org\/10.1177\/00034894241264380","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9917_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jasc.2021.08.004","volume":"11[2]","author":"RE Glass","year":"2022","unstructured":"Glass RE, Marotti JD, Kerr DA, Levy JJ, Vaickus LJ, Gutmann EJ, et al. Using molecular testing to improve the management of thyroid nodules with indeterminate cytology: an institutional experience with review of molecular alterations. J Am Soc Cytopathol. 2022;11[2]:79\u201386. doi: https:\/\/doi.org\/10.1016\/j.jasc.2021.08.004","journal-title":"J Am Soc Cytopathol"},{"key":"9917_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/cyt.12981","volume":"32[4]","author":"W Li","year":"2021","unstructured":"Li W, Justice-Clark T, Cohen MB. The utility of ThyroSeq\u00ae in the management of indeterminate thyroid nodules by fine\u2010needle aspiration. Cytopathology. 2021;32[4]:505\u201312. doi:https:\/\/doi.org\/10.1111\/cyt.12981","journal-title":"Cytopathology"},{"key":"9917_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3803\/EnM.2024.2034","volume":"39[5]","author":"MY Oh","year":"2024","unstructured":"Oh MY, Choi HM, Jang J, Son H, Park SS, Song M, et al. Small Multi-Gene DNA Panel Can Aid in Reducing the Surgical Resection Rate and Predicting the Malignancy Risk of Thyroid Nodules. Endocrinol Metab. 2024;39[5]:777\u201392. doi:https:\/\/doi.org\/10.3803\/EnM.2024.2034","journal-title":"Endocrinol Metab"},{"key":"9917_CR34","doi-asserted-by":"publisher","unstructured":"Polavarapu P, Fingeret A, Yuil-Valdes A, Olson D, Patel A, Shivaswamy V, et al. Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules. J Endocr Soc. 2021;5[11]: bvab148. doi:https:\/\/doi.org\/10.1210\/jendso\/bvab148","DOI":"10.1210\/jendso\/bvab148"},{"key":"9917_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jss.2023.03.034","volume":"289","author":"LF Remer","year":"2023","unstructured":"Remer LF, Linhares SM, Scola WH, Lew JI. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS\/FLUS Thyroid Nodules. J Surg Res. 2023; 289:229\u201333. doi: https:\/\/doi.org\/10.1016\/j.jss.2023.03.034","journal-title":"J Surg Res"},{"key":"9917_CR36","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/dc.24751","volume":"49[7]","author":"SM Selvaggi","year":"2021","unstructured":"Selvaggi SM. The role of ThyroSeq V3 testing in the management of patients with indeterminate thyroid nodules on fine needle aspiration. Diagn Cytopathol. 2021;49[7]:838\u201341. doi:https:\/\/doi.org\/10.1002\/dc.24751","journal-title":"Diagn Cytopathol"},{"key":"9917_CR37","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/thy.2018.0726","volume":"29[5]","author":"TE Angell","year":"2019","unstructured":"Angell TE, Heller HT, Cibas ES, Barletta JA, Kim MI, Krane JF, et al. Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules. Thyroid. 2019;29[5]:650\u20136. doi:https:\/\/doi.org\/10.1089\/thy.2018.0726","journal-title":"Thyroid"},{"key":"9917_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/SLA.0000000000004130","volume":"272[4]","author":"SE Carty","year":"2020","unstructured":"Carty SE, Ohori NP, Hilko DA, McCoy KL, French EK, Manroa P, et al. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms [Bethesda IV Nodules]. Ann Surg. 2020;272[4]:621\u20137. doi:https:\/\/doi.org\/10.1097\/SLA.0000000000004130","journal-title":"Ann Surg"},{"key":"9917_CR39","first-page":"1087","volume":"29[8]","author":"M Endo","year":"2019","unstructured":"Endo M, Miyauchi A, Kawashima A. Long-term follow-up of indeterminate nodules. Thyroid. 2019;29[8]:1087\u201395.","journal-title":"Thyroid"},{"key":"9917_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/cyt.12920","volume":"32[2]","author":"Y Geng","year":"2021","unstructured":"Geng Y, Aguilar-Jakthong JS, Moatamed NA. Comparison of Afirma Gene Expression Classifier with Gene Sequencing Classifier in indeterminate thyroid nodules: A single\u2010institutional experience. Cytopathology. 2021;32[2]:187\u201391. doi:https:\/\/doi.org\/10.1111\/cyt.12920","journal-title":"Cytopathology"},{"key":"9917_CR41","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1089\/thy.2020.0801","volume":"31[9]","author":"M Gortakowski","year":"2021","unstructured":"Gortakowski M, Feghali K, Osakwe I. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules. Thyroid. 2021;31[9]:1376\u201382. doi:https:\/\/doi.org\/10.1089\/thy.2020.0801","journal-title":"Thyroid"},{"key":"9917_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4158\/EP-2018-0395","volume":"25[2]","author":"RM Harrell","year":"2019","unstructured":"Harrell RM, Eyerly-Webb SA, Golding AC, Edwards CM, Bimston DN. Statistical Comparison of Afirma Gsc and Afirma Gec Outcomes in a Community Endocrine Surgical Practice: Early Findings. Endocr Pract. 2019;25[2]:161\u20134. doi:https:\/\/doi.org\/10.4158\/EP-2018-0395","journal-title":"Endocr Pract"},{"key":"9917_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/dc.24091","volume":"47[4]","author":"J Maerki","year":"2019","unstructured":"Maerki J, Klein M, Chau K, Gimenez C, Fishbein J, Khutti S, et al. Determining the molecular test for indeterminate thyroid nodules best suited for our practice: A quality assurance study. Diagn Cytopathol. 2019;47[4]:259\u201367. doi:https:\/\/doi.org\/10.1002\/dc.24091","journal-title":"Diagn Cytopathol"},{"key":"9917_CR44","doi-asserted-by":"publisher","unstructured":"Partyka KL, Huang EC, Cramer HM, Chen S, Wu HH. Histologic and clinical follow-up of thyroid fine-needle aspirates in pediatric patients. Cancer Cytopathol. 2016;124[7]:7. doi:https:\/\/doi.org\/10.1002\/cncy.21713 PubMed PMID: 26970342.","DOI":"10.1002\/cncy.21713"},{"key":"9917_CR45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/cncy.22188","volume":"127[11]","author":"S Wei","year":"2019","unstructured":"Wei S, Veloski C, Sharda P, Ehya H. Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience. Cancer Cytopathol. 2019;127[11]:720\u20134. doi:https:\/\/doi.org\/10.1002\/cncy.22188","journal-title":"Cancer Cytopathol"},{"key":"9917_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jasc.2021.07.002","volume":"11[2]","author":"Z Yang","year":"2022","unstructured":"Yang Z, Zhang T, Layfield L, Esebua M. Performance of Afirma Gene Sequencing Classifier versus Gene Expression Classifier in thyroid nodules with indeterminate cytology. J Am Soc Cytopathol. 2022;11[2]:74\u20138. doi: https:\/\/doi.org\/10.1016\/j.jasc.2021.07.002","journal-title":"J Am Soc Cytopathol"},{"key":"9917_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000339959","volume":"56[4]","author":"M Bongiovanni","year":"2012","unstructured":"Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis. Acta Cytol. 2012;56[4]:333\u20139. doi:https:\/\/doi.org\/10.1159\/000339959","journal-title":"Acta Cytol"},{"key":"9917_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/thy.2009.0110","volume":"19[11]","author":"DS Cooper","year":"2009","unstructured":"American Thyroid Association [ATA] Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc. 2009;19[11]:11. doi:https:\/\/doi.org\/10.1089\/thy.2009.0110 PubMed PMID: 19860577.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"9917_CR49","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1245\/s10434-014-3508-x","volume":"21[6]","author":"P Aragon Han","year":"2014","unstructured":"Aragon Han P, Olson MT, Fazeli R, Prescott JD, Pai SI, Schneider EB, et al. The Impact of Molecular Testing on the Surgical Management of Patients with Thyroid Nodules. Ann Surg Oncol. 2014;21[6]:1862\u20139. doi:https:\/\/doi.org\/10.1245\/s10434-014-3508-x","journal-title":"Ann Surg Oncol"},{"key":"9917_CR50","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/thy.2023.0045","volume":"33[11]","author":"JA Fagin","year":"2023","unstructured":"Fagin JA, Nikiforov YE. Progress in Thyroid Cancer Genomics: A 40-Year Journey. Thyroid. 2023;33[11]:1271\u201386. doi:10.1089\/thy.2023.0045 PubMed PMID: 37668657; PubMed Central PMCID: PMC10664575.","journal-title":"Thyroid"},{"key":"9917_CR51","doi-asserted-by":"publisher","unstructured":"Nishino M. Less is more meets do more with less: Exploring differences in thyroid FNA molecular testing between Asian and Western practices. Cancer Cytopathol. 2023 Mar 27. doi:https:\/\/doi.org\/10.1002\/cncy.22700","DOI":"10.1002\/cncy.22700"},{"key":"9917_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/ERC-16-0512","volume":"24[3]","author":"P Valderrabano","year":"2017","unstructured":"Valderrabano P, Khazai L, Leon ME, Thompson ZJ, Ma Z, Chung CH, et al. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Endocr Relat Cancer. 2017;24[3]:127\u201336. doi:https:\/\/doi.org\/10.1530\/ERC-16-0512 PubMed PMID: 28104680.","journal-title":"Endocr Relat Cancer"},{"key":"9917_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jss.2023.03.034","volume":"289","author":"LF Remer","year":"2023","unstructured":"Remer LF, Linhares SM, Scola WH, Lew JI. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS\/FLUS Thyroid Nodules. J Surg Res. 2023; 289:229\u201333. doi: https:\/\/doi.org\/10.1016\/j.jss.2023.03.034","journal-title":"J Surg Res"},{"key":"9917_CR54","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1210\/clinem\/dgae355","volume":"110[4]","author":"F L\u00e9vesque","year":"2025","unstructured":"L\u00e9vesque F, Payne RJ, Beaudoin D, Boucher A, Fortier PH, Massicotte MH, et al. Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada\u2019s Experience. J Clin Endocrinol Metab. 2025;110[4]: e1031\u20137. doi:https:\/\/doi.org\/10.1210\/clinem\/dgae355","journal-title":"J Clin Endocrinol Metab"},{"key":"9917_CR55","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/dc.24250","volume":"47[9]","author":"KL Partyka","year":"2019","unstructured":"Partyka KL, Trevino K, Randolph ML, Cramer H, Wu HH. Risk of malignancy and neoplasia predicted by three molecular testing platforms in indeterminate thyroid nodules on fine-needle aspiration. Diagn Cytopathol. 2019;47[9]:853\u201362. doi:https:\/\/doi.org\/10.1002\/dc.24250","journal-title":"Diagn Cytopathol"},{"key":"9917_CR56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jasc.2022.01.002","volume":"11[3]","author":"B Belovarac","year":"2022","unstructured":"Belovarac B, Zhou F, Modi L, Sun W, Shafizadeh N, Negron R, et al. Evaluation of ACR TI-RADS cytologically indeterminate thyroid nodules and molecular profiles: a single-institutional experience. J Am Soc Cytopathol. 2022;11[3]:165\u201372. doi: https:\/\/doi.org\/10.1016\/j.jasc.2022.01.002","journal-title":"J Am Soc Cytopathol"},{"key":"9917_CR57","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1089\/thy.2021.0659","volume":"32[8]","author":"TX Hu","year":"2022","unstructured":"Hu TX, Nguyen DT, Patel M, Beckett K, Douek M, Masamed R, et al. The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules. Thyroid. 2022;32[8]:905\u201316. doi:https:\/\/doi.org\/10.1089\/thy.2021.0659","journal-title":"Thyroid"},{"key":"9917_CR58","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1245\/s10434-015-4486-3","volume":"22[12]","author":"JL Marti","year":"2015","unstructured":"Marti JL, Avadhani V, Donatelli LA, Niyogi S, Wang B, Wong RJ, et al. Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules. Ann Surg Oncol. 2015;22[12]:3996\u20134001. doi:https:\/\/doi.org\/10.1245\/s10434-015-4486-3","journal-title":"Ann Surg Oncol"},{"key":"9917_CR59","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/cncy.21892","volume":"125[9]","author":"NP Ohori","year":"2017","unstructured":"Ohori NP, Wolfe J, Carty SE, Yip L, LeBeau SO, Berg AN, et al. The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features [NIFTP] resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria. Cancer Cytopathol. 2017;125[9]:692\u2013700. doi:https:\/\/doi.org\/10.1002\/cncy.21892","journal-title":"Cancer Cytopathol"},{"key":"9917_CR60","doi-asserted-by":"publisher","unstructured":"Wright K, Brandler TC, Fisher JC, Rothberger GD, Givi B, Prescott J, et al. The clinical significance of the American College of Radiology [ACR] Thyroid Imaging Reporting and Data System [TI-RADS] category 5 thyroid nodules: Not as risky as we think? Surgery. 2023;173[1]:239\u201345. doi: https:\/\/doi.org\/10.1016\/j.surg.2022.06.055","DOI":"10.1016\/j.surg.2022.06.055"},{"key":"9917_CR61","doi-asserted-by":"publisher","unstructured":"Rana C, Ramakant P, Goel D, Singh A, Singh K, Babu S, et al. Effect of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features [NIFTP] Nomenclature Revision on Indian Thyroid Fine-Needle Aspiration Practice. Am J Clin Pathol. 2021 Feb 20. doi:https:\/\/doi.org\/10.1093\/ajcp\/aqaa241","DOI":"10.1093\/ajcp\/aqaa241"},{"key":"9917_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pathol.2017.11.088","volume":"50[4]","author":"A Bychkov","year":"2018","unstructured":"Bychkov A, Keelawat S, Agarwal S, Jain D, Jung CK, Hong S, et al. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology [Phila]. 2018;50[4]:411\u20137. doi: https:\/\/doi.org\/10.1016\/j.pathol.2017.11.088","journal-title":"Pathology [Phila]"},{"key":"9917_CR63","doi-asserted-by":"publisher","unstructured":"Rana C, Vuong HG, Nguyen TQ, Nguyen HC, Jung CK, Kakudo K, et al. The incidence of noninvasive follicular neoplasm with papillary like nuclear features: A meta-analysis assessing worldwide impact of the reclassification. Thyroid Off J Am Thyroid Assoc. 2021 Jun 1. doi:https:\/\/doi.org\/10.1089\/thy.2021.0158","DOI":"10.1089\/thy.2021.0158"},{"key":"9917_CR64","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s40618-021-01571-y","volume":"44[12]","author":"M Marina","year":"2021","unstructured":"Marina M, Zatelli MC, Goldoni M, Del Rio P, Corcione L, Martorana D, et al. Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study. J Endocrinol Invest. 2021;44[12]:2635\u201343. doi:https:\/\/doi.org\/10.1007\/s40618-021-01571-y","journal-title":"J Endocrinol Invest"},{"key":"9917_CR65","doi-asserted-by":"publisher","unstructured":"Sfreddo HJ, Koh ES, Zhao K, Swartzwelder CE, Untch BR, Marti JL, et al. RAS -Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance. Thyroid\u00ae. 2024; thy.2023.0544. doi:https:\/\/doi.org\/10.1089\/thy.2023.0544","DOI":"10.1089\/thy.2023.0544"},{"key":"9917_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165629","author":"YY Cho","year":"2020","unstructured":"Cho YY, Park SY, Shin JH, Oh YL, Choe JH, Kim JH, et al. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population. Int J Mol Sci. 2020;21[16]:5629. doi:https:\/\/doi.org\/10.3390\/ijms21165629","journal-title":"Int J Mol Sci"},{"key":"9917_CR67","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/cncy.22362","volume":"129[2]","author":"D Desai","year":"2021","unstructured":"Desai D, Lepe M, Baloch ZW, Mandel SJ. ThyroSeq v3 for Bethesda III and IV: An institutional experience. Cancer Cytopathol. 2021;129[2]:164\u201370. doi:https:\/\/doi.org\/10.1002\/cncy.22362","journal-title":"Cancer Cytopathol"},{"key":"9917_CR68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.surg.2018.04.062","volume":"165[1]","author":"AR Marcadis","year":"2019","unstructured":"Marcadis AR, Valderrabano P, Ho AS, Tepe J, Swartzwelder CE, Byrd S, et al. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules. Surgery. 2019;165[1]:17\u201324. doi: https:\/\/doi.org\/10.1016\/j.surg.2018.04.062","journal-title":"Surgery"},{"key":"9917_CR69","doi-asserted-by":"publisher","first-page":"e22905","DOI":"10.1002\/cncy.22905","volume":"133[1]","author":"W Hsiao","year":"2025","unstructured":"Hsiao W, Saba NF, Lubin D, Chen A, Shi Q. Risk stratification of ThyroSeq results in indeterminate thyroid lesions: A single-institution experience of clinicopathologic correlation with cytologic findings. Cancer Cytopathol. 2025;133[1]: e22905. doi:https:\/\/doi.org\/10.1002\/cncy.22905","journal-title":"Cancer Cytopathol"},{"key":"9917_CR70","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.surg.2023.05.046","volume":"175[1]","author":"R Raghunathan","year":"2024","unstructured":"Raghunathan R, Longstaff XR, Hughes EG, Li SJ, Sant VR, Tseng CH, et al. Diagnostic performance of molecular testing in indeterminate [Bethesda III and IV] thyroid nodules with H\u00fcrthle cell cytology. Surgery. 2024;175[1]:221\u20137. doi: https:\/\/doi.org\/10.1016\/j.surg.2023.05.046","journal-title":"Surgery"},{"key":"9917_CR71","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1089\/thy.2018.0733","volume":"29[8]","author":"M Endo","year":"2019","unstructured":"Endo M, Nabhan F, Porter K, Roll K, Shirley LA, Azaryan I, et al. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules. Thyroid. 2019;29[8]:1115\u201324. doi:https:\/\/doi.org\/10.1089\/thy.2018.0733","journal-title":"Thyroid"},{"key":"9917_CR72","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1089\/thy.2020.0801","volume":"31[9]","author":"M Gortakowski","year":"2021","unstructured":"Gortakowski M, Feghali K, Osakwe I. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules. Thyroid. 2021;31[9]:1376\u201382. doi:https:\/\/doi.org\/10.1089\/thy.2020.0801","journal-title":"Thyroid"},{"key":"9917_CR73","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/dc.25311","volume":"52[7]","author":"S Sirotnikov","year":"2024","unstructured":"Sirotnikov S, Griffith CC, Lubin D, Zhang C, Saba NF, Li D, et al. ThyroSeq overview on indeterminate thyroid nodules: An institutional experience. Diagn Cytopathol. 2024;52[7]:353\u201361. doi:https:\/\/doi.org\/10.1002\/dc.25311","journal-title":"Diagn Cytopathol"},{"key":"9917_CR74","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/cncy.22737","volume":"131[9]","author":"Y Tjendra","year":"2023","unstructured":"Tjendra Y, Kerr DA, Zuo Y, Menendez SG, Jorda M, Gomez-Fernandez C, et al. Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV. Cancer Cytopathol. 2023;131[9]:586\u201395. doi:https:\/\/doi.org\/10.1002\/cncy.22737","journal-title":"Cancer Cytopathol"},{"key":"9917_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.surg.2023.07.042","volume":"175[1]","author":"A Tumati","year":"2024","unstructured":"Tumati A, Egan CE, Lee-Saxton YJ, Marshall TE, Lee J, Jain K, et al. Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study. Surgery. 2024;175[1]:234\u201340. doi: https:\/\/doi.org\/10.1016\/j.surg.2023.07.042","journal-title":"Surgery"},{"key":"9917_CR76","doi-asserted-by":"publisher","first-page":"e16054","DOI":"10.7717\/peerj.16054","volume":"11","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wu X, Zhang Y, Li Z, Ge X, Chen H, et al. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification. PeerJ. 2023;11: e16054. doi:https:\/\/doi.org\/10.7717\/peerj.16054","journal-title":"PeerJ"},{"key":"9917_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.18231\/j.ijpo.2020.015","volume":"7[1]","author":"C Gupta","year":"2020","unstructured":"Gupta C, Bhardwaj S, Sharma S. The interobserver variability of thyroid fine needle aspirates using The Bethesda System for Reporting Thyroid Cytopathology. Indian J Pathol Oncol. 2020;7[1]:76\u201382. doi: https:\/\/doi.org\/10.18231\/j.ijpo.2020.015","journal-title":"Indian J Pathol Oncol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-026-09917-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-026-09917-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-026-09917-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:17:51Z","timestamp":1778563071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-026-09917-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9917"],"URL":"https:\/\/doi.org\/10.1007\/s12022-026-09917-z","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Chan Kwon Jung serves as the Associate Editor in Endocrine Pathology and had no role in the peer review or editorial decision for this manuscript. The remaining authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}